FDA Inspection 1159683 — Vitalant

Vitalant — FEI 3011010065

The FDA completed an inspection of Vitalant on Dec 17, 2021 in Granite Bay, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 17, 2021
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Granite Bay, CA (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.